A Comprehensive Review on the Application of Artificial Intelligence for Predicting Postsurgical Recurrence Risk in

Ghazal Mehri-Kakavand1, Sibusiso Mdletshe1, Alan Wang1,2,3,4,5,6

  • 1Department of Anatomy and Medical Imaging, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.

Summary

Artificial intelligence (AI) shows promise in predicting non-small cell lung cancer (NSCLC) recurrence after surgery using imaging and clinical data. Further research is needed to develop robust AI models for improved patient outcomes.